Tech Company Financing Transactions

Forge Biologics Funding Round

Forge Biologics, based in Columbus, scored $40 million from Perceptive Advisors and Drive Capital.

Transaction Overview

Company Name
Announced On
7/23/2020
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors

Perceptive Advisors (Lead Investor) (Chris Garabedian)

Drive Capital

Proceeds Purpose
Forge will use the proceeds of this financing to expand AAV manufacturing CDMO capabilities in 2020, with cGMP production capacity available by mid-2021, and for the development of a novel gene therapy pipeline.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Columbus, OH 43004
USA
Phone
Undisclosed
Email Address
Overview
Forge is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups.
Profile
Forge Biologics LinkedIn Company Profile
Social Media
Forge Biologics Company Twitter Account
Company News
Forge Biologics News
Facebook
Forge Biologics on Facebook
YouTube
Forge Biologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Timothy Miller
  Timothy Miller LinkedIn Profile  Timothy Miller Twitter Account  Timothy Miller News  Timothy Miller on Facebook
Chief Medical Officer
Maria Escolar
  Maria Escolar LinkedIn Profile  Maria Escolar Twitter Account  Maria Escolar News  Maria Escolar on Facebook
Chief Operating Officer
Jaysson Eicholtz
  Jaysson Eicholtz LinkedIn Profile  Jaysson Eicholtz Twitter Account  Jaysson Eicholtz News  Jaysson Eicholtz on Facebook
Chief Technical Officer
David Dismuke
  David Dismuke LinkedIn Profile  David Dismuke Twitter Account  David Dismuke News  David Dismuke on Facebook
VP - Bus. Development
Erandi De Silva
  Erandi De Silva LinkedIn Profile  Erandi De Silva Twitter Account  Erandi De Silva News  Erandi De Silva on Facebook
VP - Bus. Development
Magdalena Tyrpien
  Magdalena Tyrpien LinkedIn Profile  Magdalena Tyrpien Twitter Account  Magdalena Tyrpien News  Magdalena Tyrpien on Facebook
VP - Finance
Steve Goden
  Steve Goden LinkedIn Profile  Steve Goden Twitter Account  Steve Goden News  Steve Goden on Facebook
VP - Finance
Christina Perry
  Christina Perry LinkedIn Profile  Christina Perry Twitter Account  Christina Perry News  Christina Perry on Facebook
VP - Marketing
Hannah Munizza
  Hannah Munizza LinkedIn Profile  Hannah Munizza Twitter Account  Hannah Munizza News  Hannah Munizza on Facebook
VP - Regulatory Affairs
Meghan Leonard
  Meghan Leonard LinkedIn Profile  Meghan Leonard Twitter Account  Meghan Leonard News  Meghan Leonard on Facebook
VP - Regulatory Affairs
Chris Shilling
  Chris Shilling LinkedIn Profile  Chris Shilling Twitter Account  Chris Shilling News  Chris Shilling on Facebook
VP - Sales
Laura Carfagna
  Laura Carfagna LinkedIn Profile  Laura Carfagna Twitter Account  Laura Carfagna News  Laura Carfagna on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/23/2020: Mobalytics venture capital transaction
Next: 7/23/2020: Dexterity venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary